Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Price:
0.25 USD
66.67%
Market Closed
Updated:
May 17, 2024
Sonoma Pharmaceuticals Inc
Depreciation & Amortization
|
Sonoma Pharmaceuticals Inc
Depreciation & Amortization Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
|
Depreciation & Amortization
$175k
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-5%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Depreciation & Amortization
$7.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Depreciation & Amortization
$9.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
72%
|
CAGR 10-Years
31%
|
|
|
Pfizer Inc
NYSE:PFE
|
Depreciation & Amortization
$6.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
0%
|
CAGR 10-Years
0%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Depreciation & Amortization
$3.9B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Depreciation & Amortization
$1.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Sonoma Pharmaceuticals Inc's Depreciation & Amortization?
Depreciation & Amortization
175k
USD
175k
USD
Based on the financial report for Dec 31, 2023, Sonoma Pharmaceuticals Inc's Depreciation & Amortization amounts to 175k USD.
What is Sonoma Pharmaceuticals Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 10Y
-5%
-5%
Over the last year, the Depreciation & Amortization growth was 25%. The average annual Depreciation & Amortization growth rates for Sonoma Pharmaceuticals Inc have been -15% over the past three years , -18% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
